MDRNA, Inc. Issued Patent for the Use of Nucleic Acids to Treat Cancer

News   Jan 27, 2010

 
MDRNA, Inc. Issued Patent for the Use of Nucleic Acids to Treat Cancer
 
 
 

RELATED ARTICLES

APC Protein Deletion Disrupts Cell Signalling and Could Cause Autism

News

Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.

READ MORE

The Ancient Behaviour of Sleep, Conserved Throughout Evolution

News

The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.

READ MORE

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery Genomics Research Microfluidics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE